Valued at $13.1 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) operates as a clinical-stage ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all been flattened by an awful stomach bug at some point in our lives. For ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

We recently compiled a list of the 10 Firms Fall Amid Disappointing Earnings Performance. In this article, we are going to ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

We recently compiled a list of the The 10 Worst-Performing Stocks on Monday. In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against the other stocks. Ten ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to ...

A US-based pharmaceutical company known for its revolutionary mRNA technology, has completed construction of its Moderna Innovation and Technology Centre (MITC) at Harwell in Oxfordshire.